AU Patent

AU2010321707B2 — Nitric oxide delivery system

Assigned to Vero Biotech Inc · Expires 2016-03-17 · 10y expired

What this patent protects

The present invention relates to an ambulatory or stationary device for delivery of a therapeutic amount of nitnc oxide to an individual's lungs. One embodiment comprising a system for delivering a therapeutic amount of nitric oxide, comprising a liquid reservoir containing dinit…

USPTO Abstract

The present invention relates to an ambulatory or stationary device for delivery of a therapeutic amount of nitnc oxide to an individual's lungs. One embodiment comprising a system for delivering a therapeutic amount of nitric oxide, comprising a liquid reservoir containing dinitrogen tetroxide; a tube coupled to the reservoir; a first ribbed tube coupled to the tube; wherein the tube comprises a surface activated matenal with a reducing agent and a patient interface coupled to the first nbbed tube, wherein the tube converts nitrogen dioxide into nitric oxide prior to reaching the patient interface.

Drugs covered by this patent

Patent Metadata

Patent number
AU2010321707B2
Jurisdiction
AU
Classification
—
Expires
2016-03-17
Drug substance claim
No
Drug product claim
No
Assignee
Vero Biotech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.